This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Analysis of effectiveness
The basis of the analysis of effectiveness was treatment completers only. The primary health outcomes assessed were the number of diagnostic procedures performed and several outcomes related to the yield of the test, such as the type of tumour detected, duration of staging and rate of recurrences. The final outcome measure was the rate of futile surgery. The authors stated that the age and gender of the patients identified in the two study hospitals were comparable.
Effectiveness results
The average number of diagnostic procedures the patients underwent between the first visit and the final clinical stage classification was 5.1 (+/-1.5).
The most common procedures were ultrasound and abdominal computed tomography scans (48%), bone scans (36%), and computed tomography or magnetic resonance imaging scans of the brain (16%).
Overall, 50% of the patients (169 out of 337) proved to be ineligible for curative surgery as a result of clinical staging. Thoracotomy was planned for the remaining 168 patients.
In 50% of the patients the diagnostic work lasted more than 3 weeks (median: 20 days; interquartile range, IQR: 10 -31 days).
For those deemed to be operable this timeframe was 25 days (IQR: 16 -34 days), and for clinically operable patients it was 14 days (IQR: 8 -26).
For 24 of the 168 operable patients thoracotomy was cancelled for several reasons, such as benign nature of the carcinoma, pneumonia, cardiac events, deterioration of performance status, or withdrawals.
Of the 144 patients undergoing thoracotomy, the mean interval between staging and surgery was 7 days (IQR: 0 -17).
In these 144 patients (85 at MCA and 59 at VUMC), 19 tumours were benign (9 at MCA and 10 at VUMC, P<0.01), 33 cases were irresectable at surgery (10 at MCA and 23 at VUMC), 20 patients presented recurrence after radical surgery (13 at MCA and 7 at VUMC), and 2 cases presented other malignancies (2 at MCA).
Curative surgery was consequently futile for 74 patients (51%, 95% confidence interval, CI: 40 -60%): 34 cases (40%) at the MCA and 40 cases (68%) at the VUMC, (P<0.001).
Of all the patients with NSCLC, 21% (95% CI: 16 -25) were alive and clinically disease-free at the 12-month followup. This rate was similar at the two hospitals.
Clinical conclusions
The effectiveness analysis showed that diagnostic staging of NSCLC involved considerable effort in terms of the number of diagnostic procedures conducted and the duration of staging process, with limited success in the prevention of futile surgery procedures.
Measure of benefits used in the economic analysis
The health outcomes were left disaggregated and no summary benefit measure was used. A cost-consequences analysis
